Our top pick for
Byline Bancorp, Inc is a banks-regional business based in the US. Byline Bancorp shares (BY) are listed on the NYSE and all prices are listed in US Dollars.
|52-week range||USD$8.0468 - USD$19.99|
|50-day moving average||USD$17.0532|
|200-day moving average||USD$14.5684|
|Wall St. target price||USD$19.8|
|Dividend yield||USD$0.12 (0.62%)|
|Earnings per share (TTM)||USD$0.96|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Byline Bancorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Byline Bancorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Byline Bancorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Byline Bancorp shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$221.1 million|
|Operating margin TTM||27.64%|
|Gross profit TTM||USD$221.1 million|
|Return on assets TTM||0.63%|
|Return on equity TTM||4.82%|
|Market capitalisation||USD$757.3 million|
TTM: trailing 12 months
There are currently 235,166 Byline Bancorp shares held short by investors – that's known as Byline Bancorp's "short interest". This figure is 6.8% down from 252,347 last month.
There are a few different ways that this level of interest in shorting Byline Bancorp shares can be evaluated.
Byline Bancorp's "short interest ratio" (SIR) is the quantity of Byline Bancorp shares currently shorted divided by the average quantity of Byline Bancorp shares traded daily (recently around 137523.97660819). Byline Bancorp's SIR currently stands at 1.71. In other words for every 100,000 Byline Bancorp shares traded daily on the market, roughly 1710 shares are currently held short.
However Byline Bancorp's short interest can also be evaluated against the total number of Byline Bancorp shares, or, against the total number of tradable Byline Bancorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Byline Bancorp's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Byline Bancorp shares in existence, roughly 10 shares are currently held short) or 0.0092% of the tradable shares (for every 100,000 tradable Byline Bancorp shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Byline Bancorp.
Find out more about how you can short Byline Bancorp stock.
Dividend payout ratio: 14.29% of net profits
Recently Byline Bancorp has paid out, on average, around 14.29% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Byline Bancorp shareholders could enjoy a 0.8% return on their shares, in the form of dividend payments. In Byline Bancorp's case, that would currently equate to about $0.12 per share.
While Byline Bancorp's payout ratio might seem low, this can signify that Byline Bancorp is investing more in its future growth.
Byline Bancorp's most recent dividend payout was on 23 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 February 2021 (the "ex-dividend date").
Over the last 12 months, Byline Bancorp's shares have ranged in value from as little as $8.0468 up to $19.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Byline Bancorp's is 1.3836. This would suggest that Byline Bancorp's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Byline Bancorp, Inc. operates as the bank holding company for Byline Bank that provides a range of banking products and services to small and medium sized businesses, commercial real estate and financial sponsors, and consumers in the United States. It offers non-interest bearing accounts, money market demand accounts, savings accounts, interest bearing checking accounts, and time deposits, as well as certificates of deposit. The company also provides commercial loan products and services, including term loans, revolving lines of credit, construction financing, and cash management products; small business administration loans; and small ticket equipment leasing services, as well as online, mobile, and direct banking services. It operates through 56 branch offices in Chicago metropolitan area; and 1 branch office in Brookfield, Wisconsin. The company was formerly known as Metropolitan Bank Group, Inc. and changed its name to Byline Bancorp, Inc. in 2015. Byline Bancorp, Inc. was incorporated in 1978 and is headquartered in Chicago, Illinois.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.